A wide gap exists between the evidence-base for processes to diagnose and treat Benign Paroxysmal Positional Vertigo (BPPV) and the use of these processes in real world medicine. The proposed research seeks to narrow this gap by implementing a multi-faceted implementation strategy. BPPV is the most common peripheral vestibular disorder and causes disabling symptoms. The disorder stems from free-floating particles that enter a semi-circular canal (canaliths) of the inner ear. BPPV is diagnosed using a simple and reliable positional test, the Dix-Hallpike test (DHT). The treatment, the Canalith Repositioning Maneuver (CRM), is performed in minutes at the bedside. BPPV patients randomized to the CRM have a cure rate of 80% at 24 hours compared with only 10% of patients randomized to a sham maneuver. However, these guideline supported processes (guidelines published by the American Academy of Otolaryngology-Head and Neck Survey and the American Academy of Neurology) have not adequately disseminated into routine practice. The underuse of these processes has been demonstrated in several different settings. Preliminary results from a population-based study of emergency departments (ED) have found that, among dizziness presentations, the DHT was performed in 3.9% (137 of 3,525) and the CRM in 0.2% (8 of 3,525). Among patients diagnosed with BPPV by the treating physician, 78% did not have the DHT and 96.1% did not have a CRM. In fact, other tests (e.g., head CT scans) and treatments (e.g., medicines) are more commonly utilized in ED patients diagnosed with BPPV - a finding that further highlights inefficiencies. ED providers have ranked the topic of vertigo as the #1 priority for decision support development for adult patients. Additional preliminary data from the investigators indicates high demand among ED physicians for management support specifically for BPPV. The goal of this project is to implement BPPV processes in the ED. The central hypothesis is that a multi-faceted strategy will increase the use of BPPV processes.
In specific aim 1 of the project, the investigators will develop a theory-based, multi-faceted BPPV behavioral and educational strategy (including a web-based multimedia point of care clinical tool).
In specific aim 2, a randomized controlled trial will be ued to test the effect of a decision aid on guideline concordant practice patterns and BPPV knowledge using a previously validated method of vignette-based research.
In specific aim 3, the investigators will implement and evaluate, in a community ED setting, the effect of the implementation strategy on the use of BPPV processes using a staggered enrollment randomized trial design. Exploratory outcomes include ED efficiencies and cost of care. For this project, an outstanding trans-disciplinary team has been assembled (neurologists, otolaryngologists, community and academic emergency medicine physicians, behavioral scientists, implementation specialists, cost analyst, and technical developers). Collectively, the team has extensive content expertise across multiple domains and a history of successful behavioral intervention projects.

Public Health Relevance

Benign Paroxysmal Positional Vertigo is common and causes disabling symptoms. Guideline-supported evidence-based practices exist, but are substantially underutilized. This project aims to implement these processes in a real world care setting, which has the potential to simultaneously improve patient outcomes and healthcare efficiencies.

Agency
National Institute of Health (NIH)
Institute
National Institute on Deafness and Other Communication Disorders (NIDCD)
Type
Research Project (R01)
Project #
5R01DC012760-05
Application #
9315132
Study Section
Dissemination and Implementation Research in Health Study Section (DIRH)
Program Officer
King, Kelly Anne
Project Start
2013-08-01
Project End
2019-07-31
Budget Start
2017-08-01
Budget End
2019-07-31
Support Year
5
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Neurology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Callaghan, Brian; Reynolds, Evan; Banerjee, Mousumi et al. (2018) Longitudinal pattern of pain medication utilization in peripheral neuropathy patients. Pain :
Saber Tehrani, Ali S; Kattah, Jorge C; Kerber, Kevin A et al. (2018) Diagnosing Stroke in Acute Dizziness and Vertigo: Pitfalls and Pearls. Stroke 49:788-795
Kerber, Kevin A; Forman, Jane; Damschroder, Laura et al. (2017) Barriers and facilitators to ED physician use of the test and treatment for BPPV. Neurol Clin Pract 7:214-224
Callaghan, Brian C; Burke, James F; Skolarus, Lesli E et al. (2016) Medicare's Reimbursement Reduction for Nerve Conduction Studies: Effect on Use and Payments. JAMA Intern Med 176:697-9
Wheeler, Natalie C; Wing, Jeffrey J; O'Brien, Louise M et al. (2016) Expiratory Positive Airway Pressure for Sleep Apnea after Stroke: A Randomized, Crossover Trial. J Clin Sleep Med 12:1233-8
Callaghan, Brian; Kerber, Kevin; Langa, Kenneth M et al. (2015) Longitudinal patient-oriented outcomes in neuropathy: Importance of early detection and falls. Neurology 85:71-9
Callaghan, Brian C; Kerber, Kevin A; Pace, Robert J et al. (2015) Headache neuroimaging: Routine testing when guidelines recommend against them. Cephalalgia 35:1144-52
Kerber, Kevin A; Meurer, William J; Brown, Devin L et al. (2015) Stroke risk stratification in acute dizziness presentations: A prospective imaging-based study. Neurology 85:1869-78
Zahuranec, Darin B; Lisabeth, Lynda D; Sánchez, Brisa N et al. (2014) Intracerebral hemorrhage mortality is not changing despite declining incidence. Neurology 82:2180-6
Skolarus, Lesli E; Burke, James F; Morgenstern, Lewis B et al. (2014) Impact of state Medicaid coverage on utilization of inpatient rehabilitation facilities among patients with stroke. Stroke 45:2472-4